Related Experiment Videos
[Regulation of immunoglobulin E synthesis]
1Klinika Pneumonologii i Alergologii Instytutu Medycyny Wewnetrznej Akademii Medycznej w Lodzi.
Postepy Higieny I Medycyny Doswiadczalnej
|January 1, 1997
Summary
Understanding immunoglobulin E (IgE) production is key to treating allergies. Two signals, involving interleukins and B-cell-activating factors, regulate IgE synthesis in B cells, influencing allergic disease pathogenesis.
Area of Science:
- Immunology
- Molecular Biology
- Allergy Research
Context:
- Immunoglobulin E (IgE) is central to allergic disease pathogenesis.
- Understanding IgE synthesis regulation is crucial for developing targeted therapies.
- B cell activation for IgE production requires distinct signaling pathways.
Purpose:
- To review current knowledge on IgE synthesis mechanisms in humans.
- To elucidate the molecular events involved in IgE production.
- To discuss clinical strategies for reducing IgE levels in allergic diseases.
Summary:
- IgE synthesis in B cells requires two signals: IL-4/IL-13 for epsilon germ line transcription and B-cell-activating factor (BAFF) for switch recombination and mature RNA expression.
- T lymphocytes deliver the BAFF signal, but it can be substituted by factors like Epstein-Barr virus, CD40L, anti-CD40 antibodies, TNF-alpha, and corticosteroids.
- Numerous cytokines and factors modulate IgE production, with some enhancing (e.g., IL-2, IL-5, IL-9, IL-10) and others inhibiting it (e.g., IL-12, IL-18, IFN-gamma, TGF-beta).
Impact:
- Provides a comprehensive overview of IgE synthesis pathways.
- Highlights key molecular players and regulatory factors in IgE production.
- Informs clinical approaches to managing allergic diseases by targeting IgE levels.